These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6685628)

  • 1. The distribution of [3H]-dibromodulcitol in the central nervous system of patients with brain tumour.
    Csetényi J; Afra D; Kerpel-Fronius S; Horváth IP; Institoris L; Eckhardt S
    Eur J Cancer Clin Oncol; 1983 Oct; 19(10):1389-92. PubMed ID: 6685628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism and pharmacokinetics of dibromodulcitol (DBD, NSC-104800) in man--II. pharmacokinetics of DBD.
    Horváth IP; Csetényi J; Hindy I; Kerpel-Fronius S; Institoris I; Hegedüs I; Eckhardt S
    Eur J Cancer Clin Oncol; 1982 Nov; 18(11):1211-9. PubMed ID: 6891658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The distribution of bromine content of dibromodulcitol in the central nervous system of patients with malignant gliomas.
    Sziklai IL; Afra D; Ordogh M; Institoris L; Kerpel-Fronius S; Szabo E
    Eur J Cancer; 1990 Feb; 26(2):79-82. PubMed ID: 2157475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of dibromodulcitol in humans: a phase I study.
    Kelley SL; Peters WP; Andersen J; Furlong EA; Frei E; Henner WD
    J Clin Oncol; 1986 May; 4(5):753-61. PubMed ID: 3517245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic studies on Elobromol in children with brain tumors.
    Paál C; Erdélyi-Tóth V; Pap E; Csáki C; Ferencz T; Schuler D; Borsi JD
    Anticancer Drugs; 1994 Oct; 5(5):539-47. PubMed ID: 7858286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and metabolism of dianhydrogalactitol DAG in patients: a comparison with the human disposition of dibromodulcitol DBD.
    Horváth IP; Csetényi J; Kerpel-Fronius S; Hegedüs L; Kanyár B; Eckhardt S
    Eur J Cancer Clin Oncol; 1986 Feb; 22(2):163-71. PubMed ID: 3699079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Penetration of etoposide into human malignant brain tumors after intravenous and oral administration.
    Kiya K; Uozumi T; Ogasawara H; Sugiyama K; Hotta T; Mikami T; Kurisu K
    Cancer Chemother Pharmacol; 1992; 29(5):339-42. PubMed ID: 1312906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of adriamycin and dibromodulcitol in metastatic breast carcinoma.
    Tormey DC; Simon R; Falkson G; Bull J; Band P; Perlin E; Blom J
    Cancer Res; 1977 Feb; 37(2):529-34. PubMed ID: 832277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rat liver-mediated degradation of dibromodulcitol.
    Csetényi J; Gáti E; Hegedüs L; Horváth IP; Holczinger L
    Eur J Cancer Clin Oncol; 1985 Jul; 21(7):881-5. PubMed ID: 4043174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacokinetic study of dibromodulcitol in children with brain tumors].
    Paál K; Erdélyi-Tóth V; Pap E; Csáki C; Ferencz T; Schuler D; Borsi J
    Orv Hetil; 1994 Nov; 135(46):2527-34. PubMed ID: 7800388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incorporation of 3H-dibromodulcitol and 3H-dianhydrodulcitol into ascites tumor cells. Autoradiographic study.
    Kopper L; Lapis K; Institóris L
    Neoplasma; 1976; 23(1):47-52. PubMed ID: 1272473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dibromodulcitol-based combined postoperative chemotherapy of malignant astrocytomas and glioblastomas.
    Afra D; Kocsis B; Kerpel-Fronius S; Eckhardt S
    J Neurooncol; 1986; 4(1):65-70. PubMed ID: 3746387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism and pharmacokinetics of dibromodulcitol (DBD, NSC-104800) in man. I. Metabolites of DBD.
    Horváth IP; Csetényi J; Kerpel-Fronius S; Hindy I; Eckhardt S
    Eur J Cancer (1965); 1979 Mar; 15(3):337-44. PubMed ID: 446515
    [No Abstract]   [Full Text] [Related]  

  • 14. A phase II study of dibromodulcitol (DBD) in stage IV melanoma.
    Hopkins J; Richards F; Case D; Pope E; Jackson DV; Stuart JJ; Muss HB; White DR; Cooper MR; Spurr CL
    Am J Clin Oncol; 1984 Oct; 7(5):555-6. PubMed ID: 6507378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant therapy with dibromodulcitol and BCNU increases survival of adults with malignant gliomas. EORTC Brain Tumor Group.
    Hildebrand J; Sahmoud T; Mignolet F; Brucher JM; Afra D
    Neurology; 1994 Aug; 44(8):1479-83. PubMed ID: 8058153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Difference in CDDP penetration into CSF between selective intraarterial chemotherapy in patients with malignant glioma and intravenous or intracarotid administration in patients with metastatic brain tumor.
    Nakagawa H; Fujita T; Kubo S; Tokiyoshi K; Yamada M; Kanayama T; Hagiwara Y; Nakanomyo H; Hiraoka M
    Cancer Chemother Pharmacol; 1996; 37(4):317-26. PubMed ID: 8548876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation of BCNU-induced cytotoxicity and sister chromatid exchanges by dibromodulcitol in vitro.
    Pulst SM; Deen DF
    Anticancer Res; 1990; 10(6):1647-50. PubMed ID: 2285238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uptake of labeled dianhydrogalactitol into human gliomas and nervous tissue.
    Eckhardt S; Csetényi J; Horváth IP; Kerpel-Fronius S; Számel I; Institóris L; Szlovik F; Pásztor E; Afra D
    Cancer Treat Rep; 1977 Aug; 61(5):841-7. PubMed ID: 890693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined radiotherapy and chemotherapy with dibromodulcitol and CCNU in the postoperative treatment of malignant gliomas.
    Afra D; Kocsis B; Dobay J; Eckhardt S
    J Neurosurg; 1983 Jul; 59(1):106-10. PubMed ID: 6306179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Difluoromethylornithine enhanced uptake of tritiated putrescine in 9L rat brain tumors.
    Redgate ES; Grudziak AG; Deutsch M; Boggs SS
    Int J Radiat Oncol Biol Phys; 1997 Apr; 38(1):169-74. PubMed ID: 9212020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.